ArticleBMC ophthalmology2026
Comparative analysis of optical coherence tomography angiography metrics in primary open-angle glaucoma and ocular hypertension.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate macular ganglion cell complex (GCC) thickness and parafoveal vessel density (pfVD) using optical coherence tomography angiography (OCT-A) in patients with ocular hypertension (OHT) and early- to intermediate-stage primary open-angle glaucoma (POAG). MATERIAL AND
methodsThis cross-sectional study included 150 eyes from 56 patients with POAG and 32 patients with OHT who were under regular follow-up at the Glaucoma Unit of Istanbul University Faculty of Medicine, Department of Ophthalmology. Evaluations were conducted between November and December 2022. Additionally, 50 eyes from 25 healthy individuals were included as a control group. OCT-A imaging was performed using the Topcon DRI OCT Triton system (Topcon Corporation, Japan). Macular GCC thickness and pfVD in the superficial and deep capillary plexuses were measured and compared among groups.
resultsA total of 113 participants (74 females, 39 males) were included. No significant differences in macular GCC thickness or pfVD were observed between the control and OHT groups. In contrast, both parameters were significantly reduced in POAG eyes, with greater reductions observed in more advanced disease stages. The decrease in pfVD was more pronounced in the superficial capillary plexus compared to the deep plexus. In early-stage POAG, GCC thinning appeared more prominent than pfVD reduction. CONCLUSıON: Our findings suggest that macular GCC thickness and pfVD assessed by OCT-A are associated with glaucomatous changes. In particular, structural alterations in macular GCC may be more pronounced than vascular changes in early-stage POAG. These results indicate that macular GCC assessment may provide complementary information in the evaluation of early glaucomatous damage. However, due to the cross-sectional design of the study, no conclusions can be drawn regarding the temporal relationship between structural and vascular changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.